Upper Tract Urothelial Carcinoma: Molecular Pathogenesis and Current Treatment Strategies—A Narrative Review
Cancers · 25.07.2026 · 18 (15) · 2394
DOI: 10.3390/cancers18152394 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 25.07.2026. Verfasst von Dominik Zawadzki und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland. Die Arbeit nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wroclaw Medical University.
Abstract (Originalsprache)
Background
Upper tract urothelial carcinoma (UTUC) is a rare malignancy representing approximately 5–10% of all urothelial cancers. Key risk factors include smoking, chemical exposures, selected metabolic conditions, and hereditary cancer syndromes. This narrative review summarises current knowledge on UTUC molecular pathogenesis, major risk determinants, and contemporary therapeutic strategies.
Methods
This study was conducted as a narrative review with a structured literature search. PubMed, Web of Science, Embase, and Scopus were searched using predefined combinations of UTUC-related terms covering molecular pathogenesis, carcinogenic risk factors, and treatment strategies. The review was prepared according to SANRA principles to improve transparency and consistency; however, no formal systematic review methodology or meta-analysis was performed.
Results
Available genomic studies indicate that UTUC has a molecular profile distinct from urothelial bladder carcinoma (UBC), with recurrent alterations involving FGFR3, HRAS, KMT2D, CDKN2A, KRAS, MYC, and BRIP1. Smoking, aristolochic acid exposure, Lynch syndrome, and possibly early-onset urolithiasis contribute to carcinogenesis through distinct but incompletely understood mechanisms. Surgical treatment remains the standard of care for high-risk localised disease, whereas perioperative chemotherapy, immunotherapy, and targeted agents are expanding treatment options, particularly in advanced disease. A substantial proportion of the therapeutic evidence, however, is derived from broader urothelial carcinoma populations rather than UTUC-specific studies.
Conclusions
UTUC is biologically heterogeneous and shaped by both molecular alterations and environmental exposures. Although substantial progress has been made, important gaps remain in understanding UTUC-specific carcinogenic mechanisms and in defining evidence-based personalised treatment strategies. Better integration of molecular, environmental, and clinical data is needed to improve risk stratification and treatment selection.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Minimally Invasive and Robotic Urology, University Centre of Excellence in Urology, Wroclaw Medical University, 50-367 Wroclaw, Poland.
ORCID-Profile: Natalia Libergal, Maksymilian Mikołajczyk, Mikołaj Kisiała, Bartosz Małkiewicz
Förderung
- Wroclaw Medical University
Zitieren
APA
Zawadzki, D., Libergal, N., Nowak, J., Grzanka, H., Mikołajczyk, M., Kisiała, M., Tulski, M., Krajewski, W., Szydełko, T., & Małkiewicz, B. (2026). Upper Tract Urothelial Carcinoma: Molecular Pathogenesis and Current Treatment Strategies—A Narrative Review. Cancers, 18(15), 2394. https://doi.org/10.3390/cancers18152394
Vancouver
Zawadzki D, Libergal N, Nowak J, Grzanka H, Mikołajczyk M, Kisiała M, et al. Upper Tract Urothelial Carcinoma: Molecular Pathogenesis and Current Treatment Strategies—A Narrative Review. Cancers. 2026;18(15):2394. doi:10.3390/cancers18152394
BibTeX
@article{Zawadzki2026,
author = {Zawadzki, Dominik and Libergal, Natalia and Nowak, Jaśmina and Grzanka, Hanna and Mikołajczyk, Maksymilian and Kisiała, Mikołaj and Tulski, Michał and Krajewski, Wojciech and Szydełko, Tomasz and Małkiewicz, Bartosz},
title = {Upper Tract Urothelial Carcinoma: Molecular Pathogenesis and Current Treatment Strategies—A Narrative Review},
journal = {Cancers},
year = {2026},
volume = {18},
number = {15},
pages = {2394},
doi = {10.3390/cancers18152394}
}
EUVIMED